Pharma News

EU regulator recommends revoking approval for Novartis’ sickle cell disease drug

The EMA’s human medicines committee concluded that the benefits of Adakveo did not outweigh its risks The…

Read More »

AstraZeneca’s Ultomiris approved in Japan for prevention of relapses in patients with NMOSD

AstraZeneca has announced that Ultomiris (ravulizumab) has been approved in Japan as a long-acting C5 complement inhibitor…

Read More »

Roche Canada, pCPA conclude talks for Vabysmo eye therapy

Faricimab is expected to enhance vascular stability. Credit: Pixabay. Roche Canada has successfully concluded talks with the pan-Canadian Pharmaceutical Alliance…

Read More »

Sun Pharma, Philogen sign licence agreement for Nidlegy

Malignant melanoma on the right upper medial back, marked for biopsy. Credit: Dermanonymous / commons.wikimedia.org. Sun Pharmaceutical Industries has reached…

Read More »

Amplo receives NIH-NIAMS grant for gene therapy AMP-201

The company develops AAV-based gene therapies for neuromuscular junction disorders. Credit: THAVIS 3D on Unsplash. Amplo Biotechnology has received a…

Read More »

Medsenic amends licence agreement with Phebra for OATO

Medsenic and Phebra signed a licence agreement for OATO in May 2021. Credit: Markus Spiske on Unsplash. Biotechnology company BioSenic’s…

Read More »

Mentions of big data decreased in the pharmaceutical industry in Q1 2023

Notably, big data was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions,…

Read More »

Mentions of blockchain increased in the pharmaceutical industry in Q1 2023

Notably, blockchain was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions, ahead…

Read More »

Mentions of future of work decreased in the pharmaceutical industry in Q1 2023

Notably, future of work was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of…

Read More »

Mentions of microbiome decreased in the pharmaceutical industry in Q1 2023

Notably, microbiome was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions, ahead…

Read More »